Loading
Postbiotic / Obesity and Overweight · Interventional Study
ClinicalTrials.gov · August 14, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a completed clinical trial registration for a postbiotic supplement (resM™) versus placebo in 80 overweight adults, with primary endpoints of weight, BMI, food cravings, and metabolic markers measured at 8 weeks. No trial results have been posted to this registry record, so the efficacy or safety of the intervention cannot be assessed at this time.
Interventional, Randomized, Parallel, Double masking, Other purpose. Obesity and Overweight; age from 18 Years; to 65 Years; accepts healthy volunteers. Intervention: Postbiotic Supplement. Compared with: Placebo — Placebo Comparator. n = 80. 1 site: United States.
This is a completed clinical trial registration for a postbiotic supplement (resM™) versus placebo in 80 overweight adults, with primary endpoints of weight, BMI, food cravings, and metabolic markers measured at 8 weeks. No trial results have been posted to this registry record, so the efficacy or safety of the intervention cannot be assessed at this time.
Long-term follow-up, safety outcomes, and secondary endpoints not summarized here.
This trial is not yet informative for clinical decision-making because results have not been reported. Clinicians should await publication or posting of outcome data before considering the evidence for postbiotic supplementation in weight loss or metabolic health.
This is a completed trial registration with no results posted; the study enrolled 80 participants to evaluate a dietary supplement against placebo over 8 weeks, but outcomes have not yet been reported in this registry record.
As stated by the source record.
Quoted from the source exactly as published.
This trial is not yet informative for clinical decision-making because results have not been reported. Clinicians should await publication or posting of outcome data before considering the evidence for postbiotic supplementation in weight loss or metabolic health.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT06911073). This is a study registration, not published results. Lead sponsor: ResBiotic Nutrition, Inc.. Recruitment status: COMPLETED. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 80 participants (ACTUAL). Conditions: Obesity and Overweight. Interventions: DIETARY_SUPPLEMENT: Postbiotic; DIETARY_SUPPLEMENT: Placebo. Primary outcome measures: To determine the effect of resM™ on weight , 8 weeks; To determine the effect of resM™ on BMI , 8 weeks; To determine the effect of resM™ on food cravings , 8 weeks; To determine the effect of resM™ on blood metabolic markers , 8 weeks; To determine the effect of resM™ on blood metabolic markers , 8 weeks; To determine the effect of resM™ on blood metabolic markers , 8 weeks. Brief summary: This study aims to evaluate the impact of a specific oral postbiotic supplement on metabolic health in overweight adults.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.